Leef Brands Inc
Business description not yet wired for this issuer.
Business. Leef Brands Inc (LEEF.CD) is a pharmaceutical company engaged in pharmaceuticals and medical research. The firm operates within the Healthcare sector, specifically focusing on product sales within the Pharmaceuticals industry. No specific operating segments or geographic breakdowns are provided in the available data. The company is identified by the ticker symbol LEEF.CD.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Leef Brands Inc (LEEF.CD) is a pharmaceutical company engaged in pharmaceuticals and medical research. The firm operates within the Healthcare sector, specifically focusing on product sales within the Pharmaceuticals industry. No specific operating segments or geographic breakdowns are provided in the available data. The company is identified by the ticker symbol LEEF.CD.
Leef Brands Inc is a company in the Pharmaceuticals & Medical Research industry, primarily engaged in the development and distribution of personal care products within the healthcare sector.
Leef Brands Inc is classified under the Healthcare economic sector, within the Pharmaceuticals & Medical Research business sector, with a high confidence level of 0.92 according to verified market data.
Leef Brands Inc has a highly leveraged capital structure, with a debt-to-equity ratio of 28.43, indicating a significant reliance on debt financing. The company's liquidity position is rated as medium, with a current ratio of 0.55, suggesting limited short-term liquidity to cover immediate liabilities. Free cash flow is negative at -$6.82 million, and operating cash flow is only $162,080, further highlighting the company's cash flow constraints.
Profitability metrics are severely negative, with a return on equity of -7.48 and a return on assets of -0.12, both well below the typical thresholds for pharmaceutical companies. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to market-specific risks.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. Historical financial data shows a net loss of $5.54 million, and the company reported negative operating income of $3.20 million, indicating a lack of operational profitability.
Risk factors include a high debt load and negative net cash position, which could limit the company's ability to invest in growth or respond to market challenges. The risk assessment indicates a low potential for dilution, but the company's financial instability could lead to future capital-raising activities that may involve equity dilution.
Recent events include the filing of financial statements that highlight the company's significant losses and liquidity constraints. No recent earnings call transcripts or major corporate announcements are available in the provided data.
- Leef Brands Inc is highly leveraged, with a debt-to-equity ratio of 28.43, indicating a significant reliance on debt financing. - The company is not generating returns for its shareholders, with a return on equity of -7.48 and a return on assets of -0.12. - Leef Brands Inc has a negative free cash flow of -$6.82 million and a weak operating cash flow of $162,080, indicating cash flow constraints. - The company's financial instability and high debt load pose significant risks to its future operations and growth potential. - There is no geographic or segment diversification disclosed, increasing the company's exposure to market-specific risks.
- Leef Brands Inc (LEEF.CD) is a pharmaceutical company engaged in pharmaceuticals and medical research.
- The firm operates within the Healthcare sector, specifically focusing on product sales within the Pharmaceuticals industry.
- No specific operating segments or geographic breakdowns are provided in the available data.
- The company is identified by the ticker symbol LEEF.CD.
Bull / Bear case
Generated · model-assistedRevenue grew 22.1% year-over-year to $34.8 million, demonstrating significant top-line expansion momentum.
Net income improved 28.4% year-over-year, indicating a meaningful reduction in the company's operating losses.
Free cash flow improved 42.5% year-over-year, suggesting better cash generation despite ongoing negative flows.
Long-term debt decreased significantly from $23.1 million to $12.6 million, strengthening the balance sheet position.
The company achieved a 45.8% revenue CAGR over four years, highlighting strong historical growth trajectory.
The debt-to-equity ratio of 28.43 is in the bottom quartile, signaling extreme financial leverage risk.
Return on equity of -7.48% is in the bottom quartile, indicating poor capital utilization efficiency.
The company faces high credit risk, posing a significant threat to its financial stability and operations.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Leef Brands Inc Market data — financials · 2026-05-28